NEW YORK--(BUSINESS WIRE)--Pfizer Inc. announced today that Charles Reay Mackay, Ph.D., will join the company as Chief Scientific Officer for Pfizer’s Inflammation and Immunology Research Unit. Professor Mackay will report directly to José-Carlos Gutiérrez-Ramos, Ph.D., group vice president of BioTherapeutics Research & Development, and will be based in Pfizer’s R&D hub in Cambridge, MA.
Help employers find you! Check out all the jobs and post your resume.
